Lv41
480 积分 2024-12-23 加入
Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 inex vivoprecision cut lung slices from patients with Idiopathic Pulmonary Fibrosis
5小时前
待确认
Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients
3天前
已完结
Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 inex vivoprecision cut lung slices from patients with Idiopathic Pulmonary Fibrosis
17天前
已完结
Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 in ex vivo precision cut lung slices from patients with Idiopathic Pulmonary Fibrosis
17天前
已完结
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials
20天前
已完结
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF)
20天前
已完结
Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton
1个月前
已完结
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
1个月前
已完结
Activity of TOL-463 Against Biofilms Formed by Candida Species in an Ex Vivo Murine Vaginitis Model
1个月前
已关闭
Prudent tactics to sail the boat of PARP inhibitors as therapeutics for diverse malignancies
3个月前
已完结
皖公网安备34019202002308
